Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vimian Group AB Capital/Financing Update 2025

Apr 4, 2025

8618_rns_2025-04-04_e93e9137-cb64-4f49-865b-102cc6e1f524.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Press Release 04 April 2025 16:30:00 CEST

Vimian Group AB (publ) terminates liquidity guarantee agreement

Vimian Group AB (publ) ("Vimian") today announces that the company has terminated the liquidity guarantee agreement with Carnegie Investment Bank. The purpose of the liquidity guarantee agreement has been to promote liquidity in the company's share, reduce volatility and facilitate trading. Vimian assesses that current trading and liquidity in the share is good and that the benefit of the liquidity guarantee is limited. The agreement expires on 30 April, 2025.

For further information, please contact:

Maria Dahllöf Tullberg

Head of IR, Communications & Sustainability [email protected] +46 736 26 88 86

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market's most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com.

Attachments

Vimian Group AB (publ) terminates liquidity guarantee agreement